SBI Biotech Co., Ltd. - Product Pipeline Review - H2 2011

Global Markets Direct, October 2011, Pages: 31

SBI Biotech Co., Ltd. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “SBI Biotech Co., Ltd. - Product Pipeline Review - H2 2011” provides data on the SBI Biotech Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, SBI Biotech Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from SBI Biotech Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- SBI Biotech Co., Ltd. - Brief SBI Biotech Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of SBI Biotech Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of SBI Biotech Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the SBI Biotech Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate SBI Biotech Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of SBI Biotech Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the SBI Biotech Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with SBI Biotech Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of SBI Biotech Co., Ltd. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of SBI Biotech Co., Ltd.; SBI Biotech Co., Ltd. - Key Therapeutics; SBI Biotech Co., Ltd. - Pipeline Overview and Promising Molecules; SBI Biotech Co., Ltd. - News; SBI Biotech Co., Ltd. - Latest Updates; SBI Biotech Co., Ltd. - Pipeline; SBI Biotech Co., Ltd. - Discontinued/Dormant Projects

List of Tables
List of Figures
SBI Biotech Co., Ltd. Snapshot
SBI Biotech Co., Ltd. Overview
Key Information
Key Facts
SBI Biotech Co., Ltd. – Research and Development Overview
Key Therapeutic Areas
SBI Biotech Co., Ltd. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
SBI Biotech Co., Ltd. – Pipeline Products Glance
SBI Biotech Co., Ltd. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
SBI Biotech Co., Ltd.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
SBI Biotech Co., Ltd. – Drug Profiles
Anti-BST2 Antibody
Product Description
Mechanism of Action
R&D Progress
Cdc7 Inhibitor
Product Description
Mechanism of Action
R&D Progress
Dendritic Cell Activation Therapy
Product Description
Mechanism of Action
R&D Progress
GNKG168
Product Description
Mechanism of Action
R&D Progress
SBI Biotech Co., Ltd. – Pipeline Analysis
SBI Biotech Co., Ltd. – Pipeline Products by Therapeutic Class
SBI Biotech Co., Ltd. - Pipeline Products By Target
SBI Biotech Co., Ltd. – Pipeline Products by Route of Administration
SBI Biotech Co., Ltd. – Pipeline Products by Molecule Type
SBI Biotech Co., Ltd. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
SBI Biotech Co., Ltd., Deals Summary
SBI Biotech Co., Ltd., Pharmaceuticals & Healthcare, Deal Details
Partnerships
Medical Research Council Enters Into Co-Development Agreement With Ginkgo Biomedical
Licensing Agreements
SBI Biotech Enters Into Licensing Agreement With Changchun Huapu
SBI Biotech Enters Into Licensing Agreement With Helixir
Baylor Research Institute Enters Into Licensing Agreement With SBI Biotech
MedImmune Enters Into An Agreement With SBI Biotech
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
SBI Biotech Co., Ltd. – Pipeline by Therapy Area and Indication, H2 2011
SBI Biotech Co., Ltd. – Pipeline by Stage of Development, H2 2011
SBI Biotech Co., Ltd. – Monotherapy Products in Pipeline, H2 2011
SBI Biotech Co., Ltd. - Phase I, H2 2011
SBI Biotech Co., Ltd. - Pipeline By Therapeutic Class, H2 2011
SBI Biotech Co., Ltd. - Pipeline By Target, H2 2011
SBI Biotech Co., Ltd. – Pipeline By Route of Administration, H2 2011
SBI Biotech Co., Ltd. – Pipeline By Molecule Type, H2 2011
SBI Biotech Co., Ltd., Deals Summary
Medical Research Council Enters Into Co-Development Agreement With Ginkgo Biomedical
SBI Biotech Enters Into Licensing Agreement With Changchun Huapu
SBI Biotech Enters Into Licensing Agreement With Helixir
Baylor Research Institute Enters Into Licensing Agreement With SBI Biotech
MedImmune Enters Into An Agreement With SBI Biotech

List of Figures
SBI Biotech Co., Ltd. – Pipeline by Therapy Area and Indication, H2 2011
SBI Biotech Co., Ltd. – Pipeline by Stage of Development, H2 2011
SBI Biotech Co., Ltd. – Monotherapy Products in Pipeline, H2 2011
SBI Biotech Co., Ltd. – Pipeline By Therapeutic Class, H2 2011
SBI Biotech Co., Ltd. - Pipeline By Target, H2 2011
SBI Biotech Co., Ltd. – Pipeline By Route of Administration, H2 2011
SBI Biotech Co., Ltd. – Pipeline By Molecule Type, H2 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• SunGard - Profile - US
• eBay - Strong Execution
• Top Ten Companies In Computer Network Equipment Mfg. Industry In China
• Insight into Samsung Electronics' Notebook PC Business Model
• Amazon - Point of Realization in 2013?
• Analysis of Google Inc